Blujepa: FDA Approves First New Antibiotic in 30 Years for UTI that Outsmarts Antibiotic Resistance

Blujepa, featuring the novel antibiotic gepotidacin, is the first original oral treatment for recurrent urinary tract infections in nearly 30 years; it deploys a dual-enzyme attack to outsmart resistant bacteria, delivered in a twice-daily pill that proved as effective—or more so—than nitrofurantoin in Phase 3 trials of over 3,000 females aged 12 and up, all […]